Crossmark

Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy

Crossref DOI link: https://doi.org/10.1186/s40478-018-0556-7

Published Online: 2018-06-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ishiki, Aiko

Harada, Ryuichi http://orcid.org/0000-0001-8538-8814
Kai, Hideaki

Sato, Naomi

Totsune, Tomoko

Tomita, Naoki

Watanuki, Shoichi

Hiraoka, Kotaro

Ishikawa, Yoichi

Funaki, Yoshihito

Iwata, Ren

Furumoto, Shozo

Tashiro, Manabu

Sasano, Hironobu

Kitamoto, Tetsuyuki

Kudo, Yukitsuka

Yanai, Kazuhiko

Furukawa, Katsutoshi

Okamura, Nobuyuki

Arai, Hiroyuki
Funding

Funding for this research was provided by:

Grant-in-Aid for Research Activity Start-up (16H06621)

Grant-in-Aid for Young Scientists (15K19767)

Grant-in-Aid for Scientific Research (15H04900)

Grant-in-Aid for Scientific Research on Innovative Areas (26117003)
License Information

Text and Data Mining valid from 2018-06-29
More Information

Article History

Received: 12 June 2018

Accepted: 19 June 2018

First Online: 29 June 2018

Ethics approval and consent to participate

: All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki Declaration and its later amendments.

: Informed consent was obtained from all the individual participants included in the study and according to the institutional procedures for autopsy consents for postmortem tissue.

: NO, SF, and YK received the research funding from GE Healthcare. NO and YK own stock of CLINO Ltd.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.